Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Search results

Hromada1943
Account activated

HRConnectForum
Account activated

Hrki
First prediction

hrcasFoura
Account activated

Hrishikesh
Account activated

HRMS
Account activated

hrjobsindubai
First extensive comment

Zacks Value Investor Highlights: HRMY, NVDA and VLO
Zacks Value Investor Highlights: HRMY, NVDA and VLO

For Immediate Release

Chicago, IL – July 27, 2026 – Zacks Value Investor is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by guests to discuss

Zacks.com featured highlights include Harmony Biosciences, Invesco, General Motors, Hewlett Packard and Quanex Building
Zacks.com featured highlights include Harmony Biosciences, Invesco, General Motors, Hewlett Packard and Quanex Building

For Immediate Release

Chicago, IL – July 29, 2026 – Stocks in this week’s article are Harmony Biosciences Holdings HRMY, Invesco IVZ, General Motors GM, Hewlett Packard Enterprise HPE and Quanex

Herc Holdings Q2 Earnings Top Estimates on Rental Growth, 2026 View Up
Herc Holdings Q2 Earnings Top Estimates on Rental Growth, 2026 View Up

Herc Holdings Inc. (HRI) reported second-quarter 2026 adjusted earnings of $1.43 per share, beating the Zacks Consensus Estimate of 76 cents by 88.2%. However, earnings declined on a year-over-year

Should Value Investors Buy Harmony Biosciences (HRMY) Stock?
Should Value Investors Buy Harmony Biosciences (HRMY) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the

Harmony Biosciences Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens,  Coal company, neutral atmosphere, photo by Galina Stepanova: https://img.theapi.app/temp/0e838f13-fa33-4583-92e9-bf3375dacf70.png
Harmony Biosciences Q2 Earnings Call Highlights

Key Points

Error: Response status code does not indicate success: 500 (Internal Server Error).

Harmony Biosciences (NASDAQ:HRMY) reported second-quarter net revenue of $261.3 million, up 30% from